Vincristine, Carboplatin, and Etoposide or Observation Only in Treating Patients Who Have Undergone Surgery for Newly Diagnosed Retinoblastoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Murali Chintagumpala, MD
Children's Oncology Group
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
56 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Royal Brisbane and Women'S Hospital
Herston, Queensland, Australia
- Royal Children'S Hospital
Parkville, Victoria, Australia
- Princess Margaret Hospital for Children
Perth, Western Australia, Australia
- Cancercare Manitoba
Winnipeg, Manitoba, Canada
- Hospital Sainte-Justine
Montreal, Quebec, Canada
- L V Prasad Eye Institute
Hyderabad, India
- Starship Children'S Hospital
Grafton, Auckland, New Zealand
- Christchurch Hospital
Christchurch, New Zealand
- University of Alabama at Birmingham
Birmingham, Alabama, United States
- University of Arizona Health Sciences Center
Tucson, Arizona, United States
- Children'S Oncology Group
Arcadia, California, United States
- Southern California Permanente Medical Group
Downey, California, United States
- Children'S Hospital Los Angeles
Los Angeles, California, United States
- Rady Children'S Hospital - San Diego
San Diego, California, United States
- University of California San Francisco Medical Center-Parnassus
San Francisco, California, United States
- Children'S Hospital Colorado
Aurora, Colorado, United States
- Children'S National Medical Center
Washington D.C., District of Columbia, United States
- Lombardi Comprehensive Cancer Center at Georgetown University
Washington D.C., District of Columbia, United States
- University of Miami Miller School of Medicine-Sylvester Cancer Center
Miami, Florida, United States
- Childrens Memorial Hospital
Chicago, Illinois, United States
- University of Illinois
Chicago, Illinois, United States
- University of Iowa Hospitals and Clinics
Iowa City, Iowa, United States
- University of Kentucky
Lexington, Kentucky, United States
- Kosair Children'S Hospital
Louisville, Kentucky, United States
- Maine Children'S Cancer Program
Scarborough, Maine, United States
- Johns Hopkins University
Baltimore, Maryland, United States
- Dana-Farber Cancer Institute
Boston, Massachusetts, United States
- Massachusetts General Hospital Cancer Center
Boston, Massachusetts, United States
- Wayne State University
Detroit, Michigan, United States
- University of Minnesota Medical Center-Fairview
Minneapolis, Minnesota, United States
- Mayo Clinic
Rochester, Minnesota, United States
- the Childrens Mercy Hospital
Kansas City, Missouri, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Children'S Hospital and Medical Center of Omaha
Omaha, Nebraska, United States
- University of New Mexico Cancer Center
Albuquerque, New Mexico, United States
- Brooklyn Hospital Center
Brooklyn, New York, United States
- Carolinas Medical Center
Charlotte, North Carolina, United States
- Duke University Medical Center
Durham, North Carolina, United States
- Cincinnati Children'S Hospital Medical Center
Cincinnati, Ohio, United States
- Cleveland Clinic Foundation
Cleveland, Ohio, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2005
- Primary completion
- 30 Sept 2011
- Completion
- 30 Sept 2020
- Last update posted
- 18 Feb 2021
- Registered enrollment
- 331
- Registry id
- NCT00335738
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.